MedPath

The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation

Not Applicable
Completed
Conditions
Cardiovascular Disease
Type 2 Diabetes (T2DM)
Registration Number
NCT02707380
Lead Sponsor
NYU Langone Health
Brief Summary

This study is designed to investigate the effect of a structured resistance training program on glycemic control, measured by hemoglobin A1c (glycated hemoglobin), in patients with type 2 diabetes (T2DM) who are enrolled in outpatient cardiac rehabilitation. The investigator will compare the experimental group receiving resistance training to a control group made of patients enrolled in outpatient cardiac rehabilitation and perform 3 aerobic exercise modalities during their sessions, which is the current standard of care.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3
Inclusion Criteria
  • Diagnosis with T2DM and have been accepted for a standard outpatient cardiac rehabilitation program
  • Cognitively able to comprehend the information presented in the program
  • Cognitively able to give informed consent to participate in this study
Exclusion Criteria
  • Patients with orthopedic or neurological limitations that would prevent them from participating in the resistance training program or monitored exercise sessions.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Comparison of Stress measured by change in heart rateBaseline, One Year, 2 Years
Leg strength measured by assessing maximum weight subject can press one time on a leg press machineup to 2 years
Paired T-test to compare test-retest Perceived exertionup to 2 years
Paired T-test to compare test-retest Perceived dyspneaup to 2 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

New York University School of Medicine

🇺🇸

New York, New York, United States

New York University School of Medicine
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.